/
/
/

Bandaram Pharma Packtech Results

Financial overview

CAGR%
Sales
Profits
Returns
ROE
10Y5Y3YTTM
---8%
---5%
---14%-37%
10%10%10%8%

Peer Comparison

Symbol
SUNPHARMA-A
DIVISLAB-A
TORNTPHARM-A
ZYDUSLIFE-A
LAURUSLABS-A
CIPLA-A
DRREDDY-A
MANKIND-A
AUROPHARMA-A
LUPIN-A
BANDARAM-X
PriceM.Cap (₹)PE RatioEPS (₹)EV/EBITDAAnnual PAT
1,760.6₹419620 Cr34.6912.0762.82₹11479 Cr
9,039.95₹239714 Cr81.9534.04128.41₹2568 Cr
4,596₹174741 Cr80.1216.7297.06₹2163 Cr
1,140.75₹112119 Cr24.849.4262.53₹5040 Cr
2,020₹110008 Cr100.616.829.25₹889 Cr
1,333.7₹106061 Cr31.479.7757.87₹3879 Cr
1,220.75₹101339 Cr31.455.3263.99₹4196 Cr
2,354.8₹96244 Cr47.1213.7571.08₹1913 Cr
1,675₹95590 Cr25.7517.9596.84₹3505 Cr
1,959.2₹89391 Cr16.1730.95154.35₹5333 Cr
18.52₹34 Cr68.520.110.68₹45 L

Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
₹
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Dec 2021
₹24 Cr₹26 Cr₹15 Cr₹14 Cr₹8 Cr₹8 Cr₹10 Cr₹7 Cr₹11 Cr₹13 Cr₹7 Cr₹5 Cr₹6 Cr₹10 Cr₹5 Cr₹2 Cr₹91 L₹0
₹0₹1 L₹0₹80,000₹0₹9 L₹0₹0₹0₹3 L₹0₹0₹0₹17 L₹2 L₹0₹0₹0
₹24 Cr₹26 Cr₹15 Cr₹14 Cr₹8 Cr₹9 Cr₹10 Cr₹7 Cr₹11 Cr₹13 Cr₹7 Cr₹5 Cr₹6 Cr₹10 Cr₹5 Cr₹2 Cr₹91 L₹0
₹23 Cr₹26 Cr₹14 Cr₹13 Cr₹8 Cr₹8 Cr₹9 Cr₹6 Cr₹11 Cr₹13 Cr₹7 Cr₹5 Cr₹6 Cr₹10 Cr₹5 Cr₹3 Cr₹1 Cr₹0
₹2 Cr₹83 L₹100 L₹47 L₹63 L₹63 L₹66 L₹1 Cr₹54 L₹76 L₹47 L₹47 L₹54 L₹55 L₹77 L₹9 L-₹20 L₹0
₹42 L₹46 L₹34 L₹25 L₹46 L-₹10 L₹24 L₹26 L₹21 L₹32 L₹17 L₹17 L₹29 L₹13 L₹14 L₹10 L₹6 L₹0
₹92 L₹12 L₹53 L₹8 L₹4 L₹20 L₹27 L₹67 L₹18 L₹25 L₹12 L₹12 L₹7 L₹31 L₹43 L-₹25 L-₹32 L₹0
₹68 L₹9 L₹35 L₹6 L₹3 L₹16 L-₹1 L₹67 L₹18 L₹19 L₹12 L₹7 L₹7 L₹31 L₹43 L-₹25 L-₹32 L₹0

Balance Sheet

Consolidated
Standalone
₹
%
Name
Equity And Liabilities
Share Capital
Total Reserves
Reserve excluding Revaluation Reserve
Shareholder's Funds
Minority Interest
Secured Loans
Unsecured Loans
Deferred Tax Assets / Liabilities
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Borrowings
Short Term Provisions
Total Current Liabilities
Total Liabilities
Total Debt
Assets
Gross Block
Less Accumulated Depreciation
Net Block
Non Current Investments
Long Term Investment
Long Term Loans & Advances
Other Non Current Assets
Total Non-Current Assets
Current Assets Loans & Advances
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Miscellaneous Expenses not written off
Total Assets
Book Value
Adjusted Book Value
Mar 2025Mar 2024Mar 2023
———
₹12 Cr₹12 Cr₹3 Cr
₹65 L₹28 L₹8 L
₹65 L₹28 L₹8 L
₹13 Cr₹12 Cr₹3 Cr
₹3 Cr₹3 Cr₹2 Cr
₹2 Cr₹2 Cr₹2 Cr
₹7 Cr₹3 Cr₹6 Cr
₹7 L₹8 L₹5 L
₹9 Cr₹5 Cr₹8 Cr
———
₹4 Cr₹4 Cr₹24 L
₹1 Cr₹18 L₹37 L
₹8 Cr₹8 Cr₹7 Cr
₹35 L₹41 L₹19 L
₹14 Cr₹12 Cr₹7 Cr
₹39 Cr₹33 Cr₹20 Cr
₹17 Cr₹13 Cr₹14 Cr
———
₹6 Cr₹6 Cr₹5 Cr
₹2 Cr₹1 Cr₹0
₹4 Cr₹4 Cr₹5 Cr
₹1 Cr₹1 Cr₹0
₹1 Cr₹1 Cr₹0
₹0₹10 L₹7 L
₹3 Cr₹0₹0
₹8 Cr₹6 Cr₹5 Cr
———
₹9 Cr₹6 Cr₹3 Cr
₹19 Cr₹15 Cr₹7 Cr
₹12 L₹4 L₹16 L
₹1 Cr₹1 Cr₹1 Cr
₹2 Cr₹4 Cr₹4 Cr
₹31 Cr₹27 Cr₹15 Cr
₹17 Cr₹14 Cr₹8 Cr
₹77,000₹1 L₹2 L
₹39 Cr₹33 Cr₹20 Cr
₹11₹10₹10
₹11₹10₹4

Cash Flow

Consolidated
Standalone
₹
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Closing Cash & Cash Equivalent
Mar 2025Mar 2024Mar 2023
₹1 Cr₹1 Cr₹33 L
₹2 Cr₹2 Cr₹1 Cr
-₹8 Cr-₹7 Cr-₹2 Cr
-₹5 Cr-₹4 Cr-₹1 Cr
-₹5 Cr-₹4 Cr-₹1 Cr
-₹8 L-₹2 Cr-₹5 Cr
₹5 Cr₹6 Cr₹4 Cr
₹8 L-₹11 L-₹2 Cr
₹4 L₹16 L₹2 Cr
₹12 L₹4 L₹16 L

Fundamental Ratios

Consolidated
Standalone
Empty box

No results found

Share Price Live Stats

Open (₹)19.50
Volume (₹)5,402.00
High (₹)19.50
Upper Circuit22.92
Low (₹)18.52
Lower Circuit15.28
Prev Close19.10
52W High (₹)49.70
Price18.52
52W Low (₹)17.25

Share Market Cap & Key Ratios Overview

M.Cap (₹)34.33 Cr
Div. Yield (%)0.00
PE Ratio68.52
Debt to Equity1.36
Price to Book4.40
Book Value10.54
EPS (TTM)0.28
Face Value10.00
ROE (%)7.98

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMA-ANSE
DIVISLAB-ANSE
TORNTPHARM-ANSE
ZYDUSLIFE-ANSE
LAURUSLABS-ANSE
CIPLA-ANSE
DRREDDY-ANSE
MANKIND-ANSE
AUROPHARMA-ANSE
LUPIN-ANSE
BANDARAM-XNSE
LTP
1W Low
1W High
Market cap (₹)
1760.6+3.7 (0.21%)
1725.70
1777.40
4,19,620Cr
9039.95-286.05 (-3.07%)
8938
9450
2,39,714Cr
4596-64 (-1.37%)
4554.55
4680.30
1,74,741Cr
1140.75+25.65 (2.30%)
1108
1150.90
1,12,119Cr
2020-12.1 (-0.60%)
2008
2071
1,10,008Cr
1333.7+30.4 (2.33%)
1300.25
1336.65
1,06,061Cr
1220.75+25.65 (2.15%)
1195.65
1250.95
1,01,339Cr
2354.8-14.2 (-0.60%)
2317.80
2425.05
96,244Cr
1675-11.1 (-0.66%)
1645
1714.90
95,590Cr
1959.2-0.8 (-0.04%)
1925.85
1990
89,391Cr
18.52-0.07 (-0.38%)
17.75
19.50
34Cr

Bandaram Pharma Packtech Ltd Annual Results Key Takeaways

Operating profit (before other income, interest and exceptional items) was ₹1.54Cr; with other income of ₹0 cr, profit before interest and tax came to ₹1.34Cr. Interest expense was ₹41.7Lakh; PBT before exceptional items stood at ₹92.4Lakh. Cost mix (full year): raw materials ₹30.65Cr; employee cost ₹2.96Cr; depreciation ₹20.4Lakh; other expenses ₹22.41Cr. Basis: consolidated annual results.

Bandaram Pharma Packtech Ltd Quaterly Results Key Takeaways

Bandaram Pharma Packtech Ltd reported ₹23.95Cr total income from operations in Jun 2026, softer than ₹26.26Cr in Mar 2026 but higher than ₹8.1Cr in Jun 2025. Operating profit (before other income, interest and exceptional items) was ₹1.54Cr; with other income of ₹0 cr, profit before interest and tax came to ₹1.34Cr. Interest expense was ₹41.7Lakh, taking profit before tax to ₹92.4Lakh. After tax of ₹24.1Lakh, profit after tax stood at ₹68.3Lakh (vs ₹8.7Lakh in Mar 2026 and ₹2.5Lakh in Jun 2025).